LIK 066, Novartis, for the treatment of type 2 diabetes
LIK-066, a new flozin on the horizon C23 H28 O7 . 2 C6 H11 N O, 642.7795, 1 :2 co-crystal of Example 62 : L-proline. A melting point 176°C…WO2011048112 CAS 1291095-45-8,...
View ArticleAZD 1080
. AZD 1080 2-Hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile AZD1080 is a selective, orally active,...
View ArticleNew...
CAS 1452582-16-9, 428.47, C23 H26 F2 N4 O2 1H-Indazole-3-carboxamide, 5-(2,3-difluorophenyl)-N-[[1-(2-methoxyethyl)-4-piperidinyl]methyl]- Aziende Chimiche Riunite Angelini Francesco...
View ArticleAMG-319
AMG-319 N-((1S)-1-(7-fluoro-2-(2-pyridinyl)-3-quinolinyl)ethyl)-9H-purin-6-amine, WO2008118468 (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine CAS 1608125-21-8 Chemical...
View Article4′-((5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl-thio)-methy...
Cas 1820758-44-8 C24 H18 F N3 O4 S 4′-((5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl-thio)-methyl)-4-fluorobiphenyl-2-carboxamide Glycogen synthase kinase-3 (GSK-3) is a...
View ArticleUSP revises Chapter on Pharmaceutical Water
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: Changes to the fundamental monograph on pharmaceutical water <1231> Water for Pharmaceutical Purposes from the US-American...
View ArticleMirogabalin
Mirogabalin, A-2000700, DS-5565 1138245-13-2, C12H19NO2, 209.28 [(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid...
View ArticleZydus gets USFDA nod for clinical trials of Saroglitazar
November 19, 2015 New Delhi: Zydus Cadila has received US health regulator’s nod to initiate phase II clinical trials of Saroglitazar, its new drug for treating high fat levels in body due to...
View ArticleAtagabalin
Atagabalin Trans-dimethyl gababutin; UNII-JT7957Q2FB; 223445-75-8; 2-[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid DNC014878 AN-5147 PD-0200390 D09581...
View ArticleExperimental Study on Holoptelia Integrifolia Planch. in Relation to Diabetes...
Holoptelia integrifolia (Chirabilva) Experimental Study on Holoptelia Integrifolia in Relation to Diabetes Mellitus Type 2 International Journal of Pharma Research &Review,Sept2015; 4(9):21-25...
View ArticleWCK 2349 in phase II trials by Wockhardt
. CH3SO3H WCK 2349 Cas 948895-94-1 methane sulfonate Base..706809-20-3 527.563., C22 H26 F N3 O5 . C H4 O3 S...
View ArticleWCK 5107 in PHASE 1 FROM WOCKHARDT
WCK 5107 Wockhardt Limited Useful for treating bacterial infections CAS 1436861-97-0 disclosed in PCT International Patent Application No. PCT/IB2012/054290D trans- sulphuric acid...
View ArticleNew molecules from Wochkardt to treat bacterial infections
WCK ? ( Not sure) Keep watching this post……….. TRANS-SULFURIC ACID MONO-{2-[5-(3-AZETIDINYLAMINO)-METHYL-[1,3,4]- OXADIAZOL-2-YL]-7-OXO-1,6-DIAZABICYCLO[3.2.1] OCT-6-YL} ESTER TRIFLUOROACETATE...
View ArticleWCK Series by Wockhardt for treating the bacterial infection
Which WCK is it, WCK-4873 , WCK-4086, WCK ? for treating the bacterial infection. (Not sure) will arrive at correct one….keep watching……….. CAS 1627163-98-7 BASE : 1174020-25-7 C14 H16 N2 O4 . Na,...
View ArticleFlow Chemistry India 2016, 21-22 January 2016, Mumbai, India
Flow Chemistry India 2016 Date: Thursday, 21 January 2016 – Friday, 22 January 2016 Location: Mumbai, India SELECTBIO INDIA...
View ArticleNew Antibacterial oxazolidinones in pipeline by Wockhardt
WCK ? (5S)-N-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide (5S)-N- {3-[3,5-difluoro-4-(4-hydroxy-(4-methoxymethyl)-piperidin-...
View ArticleRevised USP Chapter on Visual Inspection published
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: After the long-awaited Chapter <1790> on visual inspection of injections was first published in the PF 41(1) as a draft the USP has...
View ArticleTARANABANT
Taranabant ( MK-0364) 701977-09-5 N-[3-(4-Chlorophenyl)-2(S)-(3-cyanophenyl)-1(S)-methylpropyl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yloxy]propionamide...
View ArticlePfizer’s PF 04937319 glucokinase activators for the treatment of Type 2 diabetes
PF 04937319 N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide MW 432.43 MF C22 H20 N6 O4 CAS 1245603-92-2 2-Pyrimidinecarboxamide,...
View ArticlePfizer’s PF 04991532 a Hepatoselective Glucokinase Activator Clinical...
PF 04991532 GKA PF-04991532 (S)-6-{3-cyclopentyl-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]propanamido}nicotinic acid (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic...
View Article